• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米医学策略加热“冷”卵巢癌(OC):OC 免疫治疗的下一个发展阶段。

Nanomedicine Strategies for Heating "Cold" Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC.

机构信息

Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, P. R. China.

National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, P. R. China.

出版信息

Adv Sci (Weinh). 2022 Oct;9(28):e2202797. doi: 10.1002/advs.202202797. Epub 2022 Jul 22.

DOI:10.1002/advs.202202797
PMID:35869032
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9534959/
Abstract

Immunotherapy has revolutionized cancer treatment, dramatically improving survival rates of melanoma and lung cancer patients. Nevertheless, immunotherapy is almost ineffective against ovarian cancer (OC) due to its cold tumor immune microenvironment (TIM). Many traditional medications aimed at remodeling TIM are often associated with severe systemic toxicity, require frequent dosing, and show only modest clinical efficacy. In recent years, emerging nanomedicines have demonstrated extraordinary immunotherapeutic effects for OC by reversing the TIM because the physical and biochemical features of nanomedicines can all be harnessed to obtain optimal and expected tissue distribution and cellular uptake. However, nanomedicines are far from being widely explored in the field of OC immunotherapy due to the lack of appreciation for the professional barriers of nanomedicine and pathology, limiting the horizons of biomedical researchers and materials scientists. Herein, a typical cold tumor-OC is adopted as a paradigm to introduce the classification of TIM, the TIM characteristics of OC, and the advantages of nanomedicines for immunotherapy. Subsequently, current nanomedicines are comprehensively summarized through five general strategies to substantially enhance the efficacy of immunotherapy by heating the cold OC. Finally, the challenges and perspectives of this expanding field for improved development of clinical applications are also discussed.

摘要

免疫疗法彻底改变了癌症治疗,显著提高了黑色素瘤和肺癌患者的生存率。然而,由于卵巢癌(OC)的肿瘤免疫微环境(TIM)呈冷肿瘤状态,免疫疗法对此几乎无效。许多旨在重塑 TIM 的传统药物通常与严重的全身毒性相关,需要频繁给药,并且仅显示出适度的临床疗效。近年来,新兴的纳米医学通过逆转 TIM 为 OC 展示了非凡的免疫治疗效果,因为纳米医学的物理和生化特性都可以被利用来获得最佳和预期的组织分布和细胞摄取。然而,由于对纳米医学和病理学的专业障碍缺乏认识,纳米医学在 OC 免疫治疗领域远未得到广泛探索,限制了生物医学研究人员和材料科学家的视野。在此,采用典型的冷肿瘤-OC 作为范例,介绍 TIM 的分类、OC 的 TIM 特征以及纳米医学在免疫治疗中的优势。随后,通过五种一般策略全面总结了当前的纳米医学,通过加热冷 OC 来显著提高免疫治疗的效果。最后,还讨论了这个不断发展的领域的挑战和前景,以促进临床应用的改进开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121c/9534959/9cfda40859bf/ADVS-9-2202797-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121c/9534959/3079692f6007/ADVS-9-2202797-g024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121c/9534959/e75f12dccb48/ADVS-9-2202797-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121c/9534959/3d32554acf4f/ADVS-9-2202797-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121c/9534959/d493a87020ff/ADVS-9-2202797-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121c/9534959/bbb593db290b/ADVS-9-2202797-g025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121c/9534959/98581e0f6b2c/ADVS-9-2202797-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121c/9534959/ff02260ef3b9/ADVS-9-2202797-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121c/9534959/496bca0b4302/ADVS-9-2202797-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121c/9534959/9cfda40859bf/ADVS-9-2202797-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121c/9534959/3079692f6007/ADVS-9-2202797-g024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121c/9534959/e75f12dccb48/ADVS-9-2202797-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121c/9534959/3d32554acf4f/ADVS-9-2202797-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121c/9534959/d493a87020ff/ADVS-9-2202797-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121c/9534959/bbb593db290b/ADVS-9-2202797-g025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121c/9534959/98581e0f6b2c/ADVS-9-2202797-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121c/9534959/ff02260ef3b9/ADVS-9-2202797-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121c/9534959/496bca0b4302/ADVS-9-2202797-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121c/9534959/9cfda40859bf/ADVS-9-2202797-g017.jpg

相似文献

1
Nanomedicine Strategies for Heating "Cold" Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC.纳米医学策略加热“冷”卵巢癌(OC):OC 免疫治疗的下一个发展阶段。
Adv Sci (Weinh). 2022 Oct;9(28):e2202797. doi: 10.1002/advs.202202797. Epub 2022 Jul 22.
2
Role of TIM-3 in ovarian cancer: the forsaken cop or a new noble.TIM-3 在卵巢癌中的作用:被遗弃的警察还是新的贵族。
Front Immunol. 2024 Aug 13;15:1407403. doi: 10.3389/fimmu.2024.1407403. eCollection 2024.
3
Combining Nanomedicine and Immunotherapy.纳米医学与免疫疗法的联合应用。
Acc Chem Res. 2019 Jun 18;52(6):1543-1554. doi: 10.1021/acs.accounts.9b00148. Epub 2019 May 23.
4
Emerging Sonodynamic Therapy-Based Nanomedicines for Cancer Immunotherapy.基于声动力学疗法的新兴纳米医学用于癌症免疫治疗。
Adv Sci (Weinh). 2023 Jan;10(2):e2204365. doi: 10.1002/advs.202204365. Epub 2022 Nov 27.
5
Tumor-Targeted Nanomedicine for Immunotherapy.肿瘤靶向纳米医学免疫治疗。
Acc Chem Res. 2020 Dec 15;53(12):2765-2776. doi: 10.1021/acs.accounts.0c00518. Epub 2020 Nov 8.
6
Carrier-Free Nanomedicine for Cancer Immunotherapy.无载体纳米医学用于癌症免疫治疗。
J Biomed Nanotechnol. 2022 Apr 1;18(4):939-956. doi: 10.1166/jbn.2022.3315.
7
Immunotherapy and the ovarian cancer microenvironment: Exploring potential strategies for enhanced treatment efficacy.免疫疗法与卵巢癌微环境:探索增强治疗效果的潜在策略。
Immunology. 2024 Sep;173(1):14-32. doi: 10.1111/imm.13793. Epub 2024 Apr 15.
8
Tumor-Microenvironment-Responsive Nanomedicine for Enhanced Cancer Immunotherapy.肿瘤微环境响应型纳米医学用于增强癌症免疫治疗。
Adv Sci (Weinh). 2022 Jan;9(1):e2103836. doi: 10.1002/advs.202103836. Epub 2021 Nov 19.
9
Modulating the tumor immune microenvironment with nanoparticles: A sword for improving the efficiency of ovarian cancer immunotherapy.利用纳米颗粒调节肿瘤免疫微环境:提高卵巢癌免疫治疗效率的利剑。
Front Immunol. 2022 Dec 1;13:1057850. doi: 10.3389/fimmu.2022.1057850. eCollection 2022.
10
Identification and validation of pyroptosis-related gene landscape in prognosis and immunotherapy of ovarian cancer.鉴定和验证卵巢癌预后和免疫治疗中的焦亡相关基因图谱。
J Ovarian Res. 2023 Jan 27;16(1):27. doi: 10.1186/s13048-022-01065-2.

引用本文的文献

1
NIR-Responsive Microbubble Delivery Platforms for Controlled Drug Release in Cancer Therapy.用于癌症治疗中可控药物释放的近红外响应性微泡递送平台
Materials (Basel). 2025 Jun 10;18(12):2725. doi: 10.3390/ma18122725.
2
Single-cell RNA sequencing reveals the role of GTF2F2 in ovarian cancer oncogenesis and progression.单细胞RNA测序揭示了GTF2F2在卵巢癌发生和进展中的作用。
J Ovarian Res. 2025 May 29;18(1):114. doi: 10.1186/s13048-025-01686-3.
3
Nanotechnology and nanobots unleashed: pioneering a new era in gynecological cancer management - a comprehensive review.

本文引用的文献

1
Mechanistic insights into the interplays between neutrophils and other immune cells in cancer development and progression.深入了解中性粒细胞与其他免疫细胞在癌症发展和演进中的相互作用的机制。
Cancer Metastasis Rev. 2022 Jun;41(2):405-432. doi: 10.1007/s10555-022-10024-8. Epub 2022 Mar 21.
2
Emerging perspectives on growth factor metabolic relationships in the ovarian cancer ascites environment.卵巢癌腹水微环境中生长因子代谢关系的新观点。
Semin Cancer Biol. 2022 Nov;86(Pt 2):709-719. doi: 10.1016/j.semcancer.2022.03.004. Epub 2022 Mar 5.
3
Development of a Dendritic Cell/Tumor Cell Fusion Cell Membrane Nano-Vaccine for the Treatment of Ovarian Cancer.
纳米技术与纳米机器人的应用:开创妇科癌症管理的新时代——全面综述
Cancer Chemother Pharmacol. 2025 Jan 4;95(1):18. doi: 10.1007/s00280-024-04747-4.
4
Examining the evidence for immune checkpoint therapy in high-grade serous ovarian cancer.审视高级别浆液性卵巢癌中免疫检查点疗法的证据。
Heliyon. 2024 Oct 5;10(20):e38888. doi: 10.1016/j.heliyon.2024.e38888. eCollection 2024 Oct 30.
5
The T cell-mediated tumor killing patterns revealed tumor heterogeneous and proposed treatment recommendation in ovary cancer.T细胞介导的肿瘤杀伤模式揭示了卵巢癌的肿瘤异质性并提出了治疗建议。
Discov Oncol. 2024 Dec 5;15(1):753. doi: 10.1007/s12672-024-01635-4.
6
Recent advances in nanogels for drug delivery and biomedical applications.用于药物输送和生物医学应用的纳米凝胶的最新进展。
Biomater Sci. 2024 Nov 19;12(23):6006-6018. doi: 10.1039/d4bm00224e.
7
Nanotechnology for boosting ovarian cancer immunotherapy.纳米技术助力卵巢癌免疫治疗。
J Ovarian Res. 2024 Oct 14;17(1):202. doi: 10.1186/s13048-024-01507-z.
8
Role of TIM-3 in ovarian cancer: the forsaken cop or a new noble.TIM-3 在卵巢癌中的作用:被遗弃的警察还是新的贵族。
Front Immunol. 2024 Aug 13;15:1407403. doi: 10.3389/fimmu.2024.1407403. eCollection 2024.
9
Unveiling the shield: Troglitazone's impact on epilepsy-induced nerve injury through ferroptosis inhibition.揭示盾牌:曲格列酮通过抑制铁死亡对癫痫诱导的神经损伤的影响。
CNS Neurosci Ther. 2024 Aug;30(8):e14911. doi: 10.1111/cns.14911.
10
"Target-and-release" nanoparticles for effective immunotherapy of metastatic ovarian cancer.用于转移性卵巢癌有效免疫治疗的“靶向-释放”纳米颗粒。
bioRxiv. 2024 Jul 7:2024.07.05.602135. doi: 10.1101/2024.07.05.602135.
树突状细胞/肿瘤细胞融合细胞膜纳米疫苗的研制及其在卵巢癌治疗中的应用。
Front Immunol. 2022 Feb 17;13:828263. doi: 10.3389/fimmu.2022.828263. eCollection 2022.
4
Harnessing reactive oxygen/nitrogen species and inflammation: Nanodrugs for liver injury.利用活性氧/氮物种与炎症反应:用于肝损伤的纳米药物
Mater Today Bio. 2022 Feb 8;13:100215. doi: 10.1016/j.mtbio.2022.100215. eCollection 2022 Jan.
5
VSSP abrogates murine ovarian tumor-associated myeloid cell-driven immune suppression and induces M1 polarization in tumor-associated macrophages from ovarian cancer patients.VSSP 废除了小鼠卵巢肿瘤相关髓系细胞驱动的免疫抑制,并诱导了卵巢癌患者肿瘤相关巨噬细胞中的 M1 极化。
Cancer Immunol Immunother. 2022 Oct;71(10):2355-2369. doi: 10.1007/s00262-022-03156-x. Epub 2022 Feb 15.
6
Bioinspired Electron Polarization of Nanozymes with a Human Self-Generated Electric Field for Cancer Catalytic Therapy.利用人类自身产生的电场对纳米酶进行生物启发式电子极化用于癌症催化治疗
Adv Mater. 2022 Apr;34(15):e2109568. doi: 10.1002/adma.202109568. Epub 2022 Mar 7.
7
Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy.通过自噬的激活,XBP1 的遗传和药理学抑制可防止 APAP 肝毒性。
Cell Death Dis. 2022 Feb 10;13(2):143. doi: 10.1038/s41419-022-04580-8.
8
Epigenetic state determines inflammatory sensing in neuroblastoma.表观遗传学状态决定神经母细胞瘤中的炎症感应。
Proc Natl Acad Sci U S A. 2022 Feb 8;119(6). doi: 10.1073/pnas.2102358119.
9
Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56CD16 subset.Toll 样受体 8 激动剂主要通过靶向 CD56CD16 亚群改善 NK 细胞功能。
J Immunother Cancer. 2022 Jan;10(1). doi: 10.1136/jitc-2021-003385.
10
Immune-checkpoint inhibitors: long-term implications of toxicity.免疫检查点抑制剂:毒性的长期影响。
Nat Rev Clin Oncol. 2022 Apr;19(4):254-267. doi: 10.1038/s41571-022-00600-w. Epub 2022 Jan 26.